University of South Carolina, Columbia, SC, USA.
Louisiana State University, Baton Rouge, LA, USA.
J Health Soc Behav. 2023 Jun;64(2):192-208. doi: 10.1177/00221465221136252. Epub 2022 Nov 28.
The United States is experiencing a demographic transition toward older motherhood. Biomedicine classifies pregnancies among all women of advanced maternal age (AMA) as high-risk; paradoxically, women having first births at AMA are typically economically and racially privileged, which can reduce the risk of risks. This article examines the implications of the biomedicalization of AMA for first-time mothers, age 35 and older, using qualitative interviews. We find participants had substantial cultural health capital, which informed their critiques of AMA and the medical model of birth. When they found themselves subjected to biomedical protocols and concerned about reproductive risk as their pregnancies progressed, their subsequent biomedical subjectification compelled most to accept biomedical interventions. Consequently, some participants had traumatic birth experiences. Our findings illustrate that while first-time mothers of AMA anticipated that they would have more control over the birth process because of their advantages, ultimately, most did not.
美国正经历着生育年龄向高龄化的转变。 生物医学将所有高龄产妇(AMA)的妊娠都归类为高风险;具有讽刺意味的是,初次生育年龄达到 AMA 的女性通常在经济和种族上享有特权,这可以降低风险。 本文使用定性访谈研究了 AMA 对首次生育年龄为 35 岁及以上的母亲的影响。 我们发现参与者拥有大量的文化健康资本,这使他们对 AMA 和生育的医学模式提出了批评。 当她们发现自己被生物医学方案所左右,并且随着妊娠的进展对生殖风险感到担忧时,她们随后的生物医学主体化迫使大多数人接受生物医学干预。 因此,一些参与者经历了创伤性的分娩体验。 我们的研究结果表明,尽管 AMA 的初产妇预计由于她们的优势,她们将对分娩过程有更多的控制,但最终大多数人并未如此。